Method for determining genotoxic impurities in doxofylline bulk drugs

A determination method and genotoxicity technology are applied in the field of determination of genotoxic impurities in doxofylline raw materials, and achieve the effects of reducing the loss of fixative solution, purifying test background and ensuring accuracy

Active Publication Date: 2020-07-17
陕西省食品药品监督检验研究院
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Aiming at the deficiencies in the prior art, in order to solve the practical problem that the two genotoxic impurities of vinyl acetate and/or 2-bromo-1,1-dioxyethane are lacked

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining genotoxic impurities in doxofylline bulk drugs
  • Method for determining genotoxic impurities in doxofylline bulk drugs
  • Method for determining genotoxic impurities in doxofylline bulk drugs

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0092] Example 1:

[0093] 1) Sample preparation:

[0094] Mixed standard series solution preparation: accurately weigh the appropriate amount of each reference substance, and use N,N-dimethylformamide to prepare a vinyl acetate concentration of 3.846mg / ml, 2-bromo-1,1-dioxyethane concentration Single reference substance stock solution of 0.3167mg / ml, respectively accurately measure 1ml of single reference substance stock solution into the same 100ml volumetric flask, add N,N-dimethylformamide to dilute and dilute to the mark to make a mixed control The stock solution of the product, and then accurately draw the appropriate amount of the stock solution of the mixed reference substance, and dilute it to the vinyl acetate concentration of 0.769μg / ml, 1.23μg / ml, 1.54μg / ml, 1.92μg / ml, 2.31μg / ml, 2- Bromo-1,1-dioxyethane concentration is 0.0633μg / ml, 0.101μg / ml, 0.127μg / ml, 0.158μg / ml, 0.190μg / ml mixed standard series solutions;

[0095] Preparation of test product: accurately weigh out...

Example Embodiment

[0108] Example 2-7

[0109] Except for the preparation of the test product using the following method, the same measurement conditions and procedures as in Example 1 were used.

[0110] Preparation of the test product: accurately weigh out the crude and finished doxofylline (provided by Shaanxi Bosen Biopharmaceutical Co., Ltd.) 0.3g into a 10ml volumetric flask, add an appropriate amount of N,N-dimethylformamide, shake and mix well , Seal and ultrasonic for 1min until the sample is completely dissolved, add N,N-dimethylformamide to volume, shake well, pass through a 0.22μm filter membrane, and use the filtrate as the test sample.

[0111] The measured gas chromatogram is as image 3 Shown. image 3 It is the gas chromatography-mass spectrometry analysis pattern of the sample.

[0112] The content determination results of the samples are shown in Table 2-7 below.

[0113] Table 2 Sample content determination results

[0114]

[0115] Table 3 Sample content determination results

[0116] ...

Example Embodiment

[0127] Example 3 Methodological investigation

[0128] The methodological investigation of the specificity, linearity, precision, repeatability, accuracy, stability, detection limit and quantification limit of the two genotoxic impurities in doxofylline bulk drug was carried out. The specific inspection methods are:

[0129] 1. Linear investigation

[0130] Precisely weigh the appropriate amount of each reference substance, and use N,N-dimethylformamide to prepare vinyl acetate with concentrations of 0.769μg / ml, 1.23μg / ml, 1.54μg / ml, 1.92μg / ml, 2.31μg / ml, respectively , 2-bromo-1,1-dioxyethane concentration of 0.0633μg / ml, 0.101μg / ml, 0.127μg / ml, 0.158μg / ml, 0.190μg / ml mixed standard series solution (incremental concentration The sequence is abbreviated as std1 solution, std2 solution, std3 solution, std4 solution and std5 solution). Inject the mixed standard series solution into the gas chromatography-mass spectrometer, measure the corresponding peak area, use the concentration o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The invention relates to the technical field of drug analysis, in particular to a method for determining genotoxic impurities in doxofylline bulk drugs. According to the determination method, a gas chromatography-mass spectrometry method is adopted for determination. The method is high in sensitivity, and two genotoxic impurities can be simply, quickly and accurately measured at the same time.

Description

technical field [0001] The invention belongs to the technical field of drug analysis, in particular to a method for determining genotoxic impurities in doxofylline raw materials. Background technique [0002] Doxofylline, a derivative of methylxanthine, is a bronchodilator that can relax tracheal smooth muscle and inhibit asthma by inhibiting phosphodiesterase in smooth muscle cells. [0003] [0004] Doxofylline uses vinyl acetate and 2-bromo-1,1-dioxyethane in the synthesis process, and this structure has potential genotoxicity. According to the usage and dosage of this drug preparation, the impurity limit of the above-mentioned genotoxic impurities is 20ppm, adopting the separation and analysis method of general liquid chromatography and gas chromatography, the determination sensitivity of these two genotoxic impurities is more difficult to meet the control requirements of drug inspection. [0005] Therefore no matter from drug quality control or quality standard rese...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06G01N30/72
CPCG01N30/02G01N30/06G01N30/72G01N2030/025G01N2030/062
Inventor 罗晶戴涌柳小秦安学霞黄佳焦文冬刘文龙唐娜魏亚宁吴沛佳
Owner 陕西省食品药品监督检验研究院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products